首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse
【24h】

Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse

机译:性别和发育阶段对小鼠肝致癌物急性肝毒性和炎症反应的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The incidence of liver cancer is higher in men than in women. This sex difference is also observed in murine tumor induction models that result in the appearance of liver tumors in adult mice following their exposure on postnatal days 8 and/or 15 to carcinogens such as 4-aminobiphenyl (ABP) or diethylnitrosamine (DEN). Previous studies performed in adult mice showed that acute hepatotoxic and inflammatory responses to high-dose DEN exposure were greater in males than in females, leading to the suggestion that these responses could account for the sex difference in tumor development. We also recently observed that female but not male mice exposed postnatally to ABP had slightly increased expression of the antioxidant defense genes Nqo1 and Ggt1, which are regulated by the oxidative stress response protein nuclear factor erythroid 2-related factor 2 (NRF2), while expression of Hmox1 was increased in both sexes. The goal of the present study was therefore to compare selected acute hepatotoxic, inflammatory and oxidative stress defense responses to ABP, DEN, or the prototype hepatotoxicant carbon tetrachloride (CCl4), in male and female mice exposed to these chemicals either postnatally or as adults. Exposure of adult mice to ABP, DEN or CCI4 produced a 2-fold greater acute elevation in serum levels of the hepatotoxicity biomarker alanine aminotransferase (ALT) in males than in females, while levels of the inflammatory biomarker interleukin-6 (IL-6) showed no sex difference. However, treatment of immature mice with either ABP or DEN using standard tumor -inducing postnatal exposure protocols produced no increase in serum ALT or IL-6 levels in either males or females, while CCI4 produced a 40-fold ALT elevation but with no sex difference. Basal expression of the NRF2-responsive gene Nqo1 was higher in adult females than in males, but there was no sex difference in basal expression of Ggt1 or Hmox1. Sexually immature animals showed no sex difference in basal expression of any of the three genes. Postnatal DEN exposure modestly increased the expression of Ggtl only in male mice and Nqo1 in both sexes, while CCI4 slightly increased expression of Ggt1 in both males and females and Nqol only in females. Taken together, our results make it unlikely that acute hepatotoxic, inflammatory or NRF2-activated gene responses account for the male predominance in liver tumor growth following postnatal carcinogen exposure in mice. Our findings also suggest that acute toxicity studies performed in adult mice should be interpreted with caution when extrapolating potential mechanisms to liver carcinogenesis models that commonly use postnatally exposed mice. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
机译:男性肝癌的发病率高于女性。在鼠肿瘤诱导模型中也观察到这种性别差异,导致成年小鼠在出生后第8天和/或第15天暴露于致癌物(如4-氨基联苯(ABP)或二乙基亚硝胺(DEN))后出现肝肿瘤。先前在成年小鼠中进行的研究表明,雄性对大剂量DEN暴露的急性肝毒性和炎症反应比雌性要大,这提示这些反应可以解释肿瘤发展中的性别差异。我们最近还观察到,在产后暴露于ABP的雌性而非雄性小鼠中,抗氧化防御基因Nqo1和Ggt1的表达略有增加,而抗氧化防御基因Nqo1和Ggt1受氧化应激反应蛋白核因子红系2相关因子2(NRF2)的调控,而表达男女中Hmox1的数量均增加。因此,本研究的目的是在出生后或成年后暴露于这些化学物质的雄性和雌性小鼠中比较对ABP,DEN或原型肝毒性四氯化碳(CCl4)的选定急性肝毒性,炎症和氧化应激防御反应。成年小鼠暴露于ABP,DEN或CCI4可使雄性肝毒性生物标志物丙氨酸氨基转移酶(ALT)血清水平的急性升高比雌性高2倍,而炎性生物标志物白介素6(IL-6)的水平升高没有性别差异。然而,使用标准的诱导肿瘤的出生后暴露方案,用ABP或DEN治疗未成熟小鼠,无论雄性还是雌性,血清ALT或IL-6水平均不会升高,而CCI4可使ALT升高40倍,但无性别差异。成年女性的NRF2反应基因Nqo1的基础表达高于男性,但Ggt1或Hmox1的基础表达没有性别差异。有性不成熟的动物在这三个基因中任何一个的基础表达上都没有性别差异。产后DEN暴露仅在雄性小鼠和Nqo1中均增加了性别的Ggtl表达,而CCI4在雌性和雌性中均略微增加了Ggt1的表达,仅雌性中增加了Nqol。两者合计,我们的结果使得急性肝毒性,炎症或NRF2激活的基因应答不太可能解释小鼠出生后致癌物暴露后肝脏肿瘤生长中的男性优势。我们的发现还表明,当将可能的机制外推至通常使用出生后暴露的小鼠的肝癌发生模型时,应谨慎解释在成年小鼠中进行的急性毒性研究。 (C)2016 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号